Correction: JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM)

Affiliations

• ¹ Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Aza-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. iida@med.nagoya-cu.ac.jp.
• ² Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Shiwa-gun, Iwate Prefecture, Japan.
• ³ Department of Hematology, NHO Okayama Medical Center, Okayama City, Okayama Prefecture, Japan.
• ⁴ Faculty of Transdisciplinary Sciences for Innovation, Institute of Transdisciplinary Sciences for Innovation, Kanazawa University, Kanazawa City, Ishikawa Prefecture, Japan.
• ⁵ Department of Hematology, Japanese Red Cross Medical Center, Shibuya-ku, Tokyo, Japan.
• ⁶ Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
• ⁷ Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima City, Tokushima Prefecture, Japan.